| Log in

Alkem, Dr Lal PathLabs to make stock market debut next week

By PTI
17 December, 2015

Drug maker Alkem Laboratories and diagnostic chain Dr Lal PathLabs, which recently concluded initial public offerings successfully, would list their shares on the stock exchanges on December 23.

The equity shares would be listed on BSE as well as the National Stock Exchange (NSE).

Alkem and Dr Lal PathLabs would list their shares on the stock exchanges on December 23, sources said.

Alkem has raised about Rs 1,350 crore at an issue price of Rs 1,050 per share from its IPO, which was oversubscribed 44.29 times. It plans to expand its footprint internationally.

It had a portfolio of 705 brands in the domestic market as on September 30.

Dr Lal’s IPO too was a huge success with 33.41 times oversubscription. The price band was fixed at Rs 540-550 per share for the Rs 638 crore IPO. It also raised over Rs 191 crore from anchor investors by selling shares at Rs 550 apiece.


Leave Your Comment
Dr Lal PathLabs, Alkem shares soar on debut

Dr Lal PathLabs, Alkem shares soar on debut

Joseph Rai 2 years ago
Diagnostics chain Dr Lal PathLabs Ltd and drugmaker Alkem Laboratories Ltd made...
Thyrocare surges on stock market debut

Thyrocare surges on stock market debut

Joseph Rai 2 years ago
Thyrocare Technologies Ltd made a spectacular debut on the stock markets on...
Thyrocare files draft IPO papers

Thyrocare files draft IPO papers

Joseph Rai 2 years ago
Thyrocare Technologies Ltd, India’s largest thyroid testing company, has...
No Comments

Alkem, Dr Lal PathLabs to make stock market debut next week

Powered by WordPress.com VIP